Radiant Logistics stock faces pressure amid logistics slowdown and acquisition integration challenges
21.03.2026 - 07:28:13 | ad-hoc-news.deRadiant Logistics, a US-based third-party logistics provider, released its fiscal Q2 2026 earnings on March 18, 2026, showing revenue growth but declining gross margins. The company posted $182.5 million in revenue, up 5% year-over-year, driven by acquisitions. However, adjusted EBITDA fell 8% to $8.2 million, reflecting softer freight rates and higher costs. Shares on NYSE American traded at $4.85 USD in early Friday trading, down 3.2% amid broader market caution on logistics.
As of: 21.03.2026
By Elena Voss, Senior Logistics Sector Analyst. Tracking North American supply chain shifts and their ripple effects on global trade flows for European investors.
Quarterly Results Reveal Mixed Picture
Radiant Logistics operates as a non-asset-based logistics firm, offering freight brokerage, trucking, and warehousing services across North America. In its latest quarter, revenue from transportation services rose modestly, but intermodal and truckload volumes dipped due to excess capacity in the US market. Management cited persistent low freight rates as the primary drag, with gross profit margins contracting to 18.4% from 20.1% a year earlier.
The integration of recent acquisitions, including the 2025 purchase of a regional less-than-truckload provider, contributed $15 million to top-line growth. Yet, one-time integration costs ate into profitability. CEO Bohn Crain emphasized disciplined cost management during the earnings call, signaling no major new deals imminent.
For DACH investors, this underscores the cyclical nature of US logistics, where spot rates influence 70% of Radiant's brokerage revenue. European firms reliant on transatlantic freight may feel similar pressures if US capacity remains high.
Official source
Find the latest company information on the official website of Radiant Logistics.
Visit the official company websiteMarket Reaction and Trading Dynamics
On NYSE American, Radiant Logistics stock (ticker RLGT) opened lower post-earnings, hitting a low of $4.72 USD before recovering slightly to $4.85 USD by midday Friday. Volume spiked 250% above average, indicating heightened investor interest. Analysts maintained a Hold rating average, with price targets ranging from $6 to $7 USD.
The stock has lagged the broader logistics sector, down 15% over the past six months on NYSE American in USD terms, compared to a 5% gain for the Dow Transport Average. This reflects investor concerns over freight recession signals from peers like CH Robinson and Echo Global Logistics.
DACH portfolios with US logistics exposure face amplified risks here, as currency hedges may not fully offset sector weakness. The euro's strength against the USD adds another layer for German-speaking investors.
Sentiment and reactions
Strategic Acquisitions Under Scrutiny
Radiant's growth-by-acquisition model has added scale, with total revenue doubling since 2020. The latest deals target niche markets like temperature-controlled logistics, aligning with e-commerce demand. However, synergies take 12-18 months to materialize, per management.
Balance sheet remains solid, with net debt to EBITDA at 1.2x, below industry peers. Free cash flow turned positive at $5 million in Q2, supporting further tuck-in buys. Risks include overpaying in a softening market, potentially diluting returns.
Logistics M&A activity cooled in early 2026, with deal values down 20% per PitchBook data. Radiant may pause expansions if rates stay depressed.
Industry Headwinds Weigh Heavy
US trucking capacity surged 5% last year, per American Trucking Associations, pressuring spot rates 15% lower. Intermodal volumes, 25% of Radiant's mix, face rail bottlenecks and port congestion. Nearshoring from China benefits Mexico routes but not fully US domestic.
Inflation cooled, but diesel prices hover at $3.40/gallon, squeezing carrier margins and forcing renegotiations. Radiant's asset-light model shields it somewhat, passing costs to customers via surcharges.
Sector tailwinds include rising e-commerce penetration, now 22% of US retail, boosting last-mile demand. Yet, Amazon's in-house fleet growth erodes brokerage share.
Risks and Key Uncertainties Ahead
Primary risks include prolonged freight recession, with truck tonnage indices down 4% year-over-year. Acquisition integration hiccups could inflate SG&A expenses, currently 15% of revenue. Regulatory changes, like potential FMCSA hours-of-service tweaks, impact carrier partners.
Currency volatility poses threats; a stronger USD hurts export volumes. Radiant's 90% North American revenue limits China exposure but ties it to US consumer spending, forecasted to slow to 2.1% in 2026.
Valuation at 8x forward EBITDA appears cheap versus peers at 10x, but earnings visibility is low. Short interest stands at 2.5%, signaling mild skepticism.
Further reading
Further developments, updates, and context on the stock can be explored quickly through the linked overview pages.
Outlook and Guidance Cautious
Radiant withdrew full-year guidance, citing macroeconomic uncertainty. Management eyes flat to low-single-digit revenue growth, with EBITDA margins stabilizing at 9-10%. Q3 volumes expected softer due to seasonal slowdowns.
Potential catalysts include truckload rate recovery if capacity exits accelerate, projected at 3-5% by ATRI. Warehouse expansion in high-growth Sunbelt markets adds revenue diversity.
Why DACH Investors Should Monitor Closely
German, Austrian, and Swiss investors with diversified portfolios often hold US small-caps for growth. Radiant's low valuation offers entry points, but logistics ties to global trade make it sensitive to ECB policy and EU-China tensions.
Handelsblatt coverage highlights US freight as a leading indicator for European industrial output. With DAX industrials exposed to automotive exports, Radiant's trends preview supply chain strains. Consider pairing with hedges like EURUSD futures.
Long-term, Radiant's asset-light model positions it for consolidation waves. At current levels on NYSE American around $4.85 USD, risk-reward skews positive for patient holders.
Disclaimer: This is not investment advice. Stocks are volatile financial instruments.
So schätzen die Börsenprofis Aktien ein!
Für. Immer. Kostenlos.

